15.43
price up icon1.65%   0.25
after-market Handel nachbörslich: 15.43
loading
Schlusskurs vom Vortag:
$15.18
Offen:
$15.65
24-Stunden-Volumen:
697.44K
Relative Volume:
1.46
Marktkapitalisierung:
$684.22M
Einnahmen:
$159.01M
Nettoeinkommen (Verlust:
$-21.72M
KGV:
-29.67
EPS:
-0.52
Netto-Cashflow:
$-20.63M
1W Leistung:
-1.41%
1M Leistung:
-12.92%
6M Leistung:
+16.19%
1J Leistung:
+124.93%
1-Tages-Spanne:
Value
$14.94
$15.65
1-Wochen-Bereich:
Value
$14.80
$15.80
52-Wochen-Spanne:
Value
$5.55
$21.00

Axogen Inc Stock (AXGN) Company Profile

Name
Firmenname
Axogen Inc
Name
Telefon
(386) 462-6817
Name
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Name
Mitarbeiter
452
Name
Twitter
@AxoGen
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
AXGN's Discussions on Twitter

Vergleichen Sie AXGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
AXGN
Axogen Inc
15.43 684.22M 159.01M -21.72M -20.63M -0.52
Medical Devices icon
ABT
Abbott Laboratories
131.73 218.91B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.05 139.37B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
348.12 134.90B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
83.37 106.90B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
70.60 41.45B 5.72B 4.17B 259.90M 6.97

Axogen Inc Stock (AXGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-17 Eingeleitet Lake Street Buy
2024-07-01 Eingeleitet Raymond James Outperform
2022-11-11 Fortgesetzt Jefferies Buy
2022-05-09 Hochstufung Canaccord Genuity Hold → Buy
2022-03-11 Fortgesetzt Cantor Fitzgerald Overweight
2020-10-23 Eingeleitet Guggenheim Buy
2020-06-16 Fortgesetzt Cantor Fitzgerald Overweight
2020-05-07 Herabstufung Canaccord Genuity Buy → Hold
2020-04-02 Herabstufung BTIG Research Buy → Neutral
2019-08-07 Herabstufung William Blair Outperform → Mkt Perform
2019-07-12 Eingeleitet Canaccord Genuity Buy
2018-03-02 Bestätigt Lake Street Buy
2018-01-05 Fortgesetzt Cantor Fitzgerald Overweight
2017-11-30 Eingeleitet Jefferies Buy
2017-11-21 Bestätigt Lake Street Buy
2017-07-31 Eingeleitet Leerink Partners Outperform
2017-06-30 Eingeleitet Cantor Fitzgerald Overweight
2017-03-06 Eingeleitet ROTH Capital Buy
2016-11-22 Hochstufung Lake Street Hold → Buy
2016-11-07 Bestätigt Wedbush Outperform
2016-11-03 Herabstufung Lake Street Buy → Hold
2016-08-04 Bestätigt Wedbush Outperform
2014-05-14 Eingeleitet Dawson James Buy
2013-10-31 Bestätigt Ladenburg Thalmann Buy
Alle ansehen

Axogen Inc Aktie (AXGN) Neueste Nachrichten

pulisher
Apr 21, 2025

Axogen and ADMA Biologics expect low to zero impact from recent tariffs - MSN

Apr 21, 2025
pulisher
Apr 21, 2025

AxoGen, Inc. (NASDAQ:AXGN) Stock Position Reduced by Geode Capital Management LLC - Defense World

Apr 21, 2025
pulisher
Apr 20, 2025

AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Alliancebernstein L.P. - Defense World

Apr 20, 2025
pulisher
Apr 19, 2025

JPMorgan Chase & Co. Sells 238,432 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

Would Axogen (NASDAQ:AXGN) Be Better Off With Less Debt? - simplywall.st

Apr 17, 2025
pulisher
Apr 14, 2025

Analysts Set AxoGen, Inc. (NASDAQ:AXGN) PT at $22.60 - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Sells 20,635 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Sei Investments Co. Purchases New Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Financial Comparison: AxoGen (NASDAQ:AXGN) & QT Imaging (NASDAQ:QTI) - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

Corebridge Financial Inc. Has $347,000 Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Apr 10, 2025
pulisher
Apr 07, 2025

AxoGen Expects Minimal Impact from New Tariffs - TipRanks

Apr 07, 2025
pulisher
Apr 03, 2025

Short Interest in AxoGen, Inc. (NASDAQ:AXGN) Declines By 18.4% - Defense World

Apr 03, 2025
pulisher
Apr 03, 2025

FY2025 EPS Estimates for AxoGen Boosted by Leerink Partnrs - Defense World

Apr 03, 2025
pulisher
Mar 29, 2025

(AXGN) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 29, 2025
pulisher
Mar 26, 2025

Shareholders Should Be Pleased With Axogen, Inc.'s (NASDAQ:AXGN) Price - Simply Wall St

Mar 26, 2025
pulisher
Mar 26, 2025

PNC Financial Services Group Inc. Decreases Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Axogen: LT Bullish, But Outcomes Weighted To Downside At This Point (NASDAQ:AXGN) - Seeking Alpha

Mar 25, 2025
pulisher
Mar 25, 2025

Charles Schwab Investment Management Inc. Has $6.87 Million Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

AxoGen appoints Rick Ditto as VP, global health economics, reimbursment & policy - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Axogen Announces Appointment of Rick Ditto as Vice - GlobeNewswire

Mar 24, 2025
pulisher
Mar 22, 2025

Bank of New York Mellon Corp Trims Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Axogen’s chief innovation officer sells $264,442 in shares - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

AxoGen, Inc. (NASDAQ:AXGN) Receives $20.75 Average Target Price from Brokerages - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

US Bancorp DE Makes New $30,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Axogen’s chief innovation officer sells $264,442 in shares By Investing.com - Investing.com UK

Mar 19, 2025
pulisher
Mar 18, 2025

Lake Street Initiates Coverage of Axogen (LSE:0HKD) with Buy Recommendation - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

AxoGen (NASDAQ:AXGN) Now Covered by Lake Street Capital - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Lake Street Initiates Coverage of Axogen (AXGN) with Buy Recommendation - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

Lake Street starts AxoGen stock with Buy, sets $30 target By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 75% - Yahoo

Mar 17, 2025
pulisher
Mar 17, 2025

Lake Street starts AxoGen stock with Buy, sets $30 target - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

Lake Street Initiates Axogen at Buy With $30 Price Target -March 17, 2025 at 08:17 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 12, 2025

AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com

Mar 12, 2025
pulisher
Mar 10, 2025

Cantor maintains AxoGen stock target at $24, bullish on growth plan - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Cantor maintains AxoGen stock target at $24, bullish on growth plan By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 08, 2025

(AXGN) Technical Data - Stock Traders Daily

Mar 08, 2025
pulisher
Mar 08, 2025

Principal Financial Group Inc. Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Cantor Fitzgerald Reaffirms “Overweight” Rating for AxoGen (NASDAQ:AXGN) - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Rhumbline Advisers Has $960,000 Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

Axogen director Amy McBride sells $100,100 in stock By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Insider Sell: Amy Wendell Sells 5,000 Shares of Axogen Inc (AXGN) - GuruFocus.com

Mar 05, 2025

Finanzdaten der Axogen Inc-Aktie (AXGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$97.44
price up icon 1.32%
medical_devices PHG
$24.14
price up icon 3.65%
medical_devices STE
$222.77
price up icon 1.82%
$66.33
price up icon 0.33%
$61.65
price up icon 1.93%
medical_devices EW
$70.60
price up icon 2.02%
Kapitalisierung:     |  Volumen (24h):